Metabolic disturbances in diabetic cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 180, Issue 1-2, 1998, Pages 53-57

  Rodrigues, Brian ^a   Cam, Margaret C ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Calcium; Cardiomyopathy; Diabetes; Lipids; Lipoprotein lipase

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL;

CARDIOMYOPATHY; DIABETES MELLITUS; FATTY ACID OXIDATION; HEART MUSCLE METABOLISM; HUMAN; LIPOLYSIS; METABOLIC DISORDER; REVIEW;

ANIMALS; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS;

EID: 0031934256     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006882805197     Document Type: Review

References (46)

1. Palumbo PJ, Elveback CR, Conolly DC: Coronary artery disease and congestive heart failure in the diabetic: Epidemiological aspects. The Rochester Diabetes Project. In: RC Scott (ed). Clinical Cardiology and Diabetes. Futura, New York, 1981, p 13
2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 229: 1749-1754, 1974
3. Ledet B, Neubauer B, Christnesen NJ, Lundback K: Diabetic cardiopathy. Diabetologia 16: 207-209, 1979
4. Hamby RI, Zoneraich S, Sherman L: Diabetic cardiomyopathy. JAMA 229: 1749-1754, 1974
5. Regan TJ, Lyons MM, Ahmed SS: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885-889, 1977
6. Miller TB Jr: Cardiac performance of isolated perfused hearts from alloxan diabetic rats. Am J Physiol 236: 808-812, 1979
7. Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Res 27: 255-270, 1985
8. Vadlamudi RVSV, Rodgers RL, McNeill JH: The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60: 902-911, 1982
9. Rodrigues B, McNeill JH: The diabetic heart: Metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26: 913-992, 1992
10. Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169-179, 1995
11. Gibbons GF: Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268: 1-13, 1990
12. Rodrigues B, Grassby PF, Battell ML, Lee SYN, McNeill JH: Hypertriglyceridemia in experimental diabetes: Relationship to cardiac dysfunction. Can J Physiol Pharmacol 72: 447-455, 1994
13. Mamo JCL, Hirano T, Sainsbury A, Fitzgerald AK, Redgrave TG: Hypertriglyceridemia is exacerbated by slow lipolysis of triacyl-glycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1128: 132-138, 1992
14. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 59: 8-13, 1979
15. West KM, Ahuja MMS, Bennett PH, Czyzyk A, Mateo de Acosta O, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krolewski AS, Miki E, Schliack V, Teuscher A, Watkins PJ, Strober JA: The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO Multi National study. Diabetes Care 6: 361-369, 1983
16. Rodrigues B, Xiang H, McNeill JH: Effects of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358-1364, 1988
17. Rodrigues B, Goyal RK, McNeill JH: Effects of hydralazine on streptozotocin-induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther 237: 292-299, 1986
18. McNeill JH, Rodrigues B: Heart function in WKY diabetic rats. J Mol Cell Cardiol 28(6): A202, 1996
19. Denton RM, Randle PJ: Concentration of glycerides and phospholipids in rat heart and gastronemius muscles. Effects of alloxan-diabetes and perfusion. Biochem J 104: 416-422, 1967
20. Kenno KA, Severson DL: Lipolysis in isolated myocardial cells from diabetic rat hearts. Am J Physiol 249: 1024-1030, 1985
21. Chattopadhyay J, Thompson EW, Schmid HHO: Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats. Lipids 25: 307-310, 1990
22. Eckel RH: Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060-1068, 1989
23. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A: Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb 14: 1445-1451, 1994
24. Hamosh M, Hamosh P: Lipoprotein lipase: Its physiological and clinical significance. Mol Aspects Med 6: 199-289, 1983
25. Elkeles RS, Hambley J: The effects of fasting and streptozotocin on hepatic triglyceride lipase activity in the rat. Diabetes 26: 58-60, 1977
26. Veeraraghavan K, Murthy K, Bauman MD, Shipp J: Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes 32: 718-722, 1983
27. Nomura T, Hagino H, Gotoh M, Iguchi A, Sakamoto N: The effects of streptozotocin diabetes on tissue specific lipase activities in the rat. Lipids 19: 594-599, 1984
28. Tavangar K, Murata Y, Pedersen ME, Goers JF, Hoffman AR, Kraemer FB: Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest 90: 1672-1678, 1992
29. O'Looney P, Maten MV, Vahouny GV: Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism. J Biol Chem 258: 12994-13001, 1983
30. Braun JEA, Severson DL: Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin. Am J Physiol 262: 663-670, 1992
31. Rodrigues B, Severson DL: Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats. Can J Physiol Pharmacol 71: 657-661, 1993
32. Mamo JCL, Hirano T, Sainsbury A, Fitzgerald AK, Redgrave TG: Hypertriglyceridemia is exacerbated by slow lipolysis of triacyl-glycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1128: 132-138, 1992
33. Rutledge JC, Goldberg IJ: Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: Evidence that LpL increases LDL accumulation in vascular tissue. J Lipid Res 35: 1152-1160, 1994
34. Fernandez-Borja M, Bellido D, Vilella E, Olivecrona G, Vilaro S: Lipoprotein lipase-mediated uptake of lipoprotein inhuman fibroblasts: Evidence for an LDL receptor-independent internalization pathway. J Lipid Res 37: 464-481, 1996
35. Tsutsumi K, Inoue Y, Shina A, Murase T: Correction of hyperti-glyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase promoting agent, in STZ-induced diabetic rats. Diabetes 44: 414-417, 1995
36. 2+ transients in isolated rabbit cardiomyocytes. J Biol Chem 268: 3767-3775, 1993
37. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981
38. Cushman SW, Wardzala LJ: Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255: 4758-4762, 1980
39. Karnieli E, Zarnowski MJ, Hissin PJ, Simpson IA, Salans LB, Cushman SW: Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. J Biol Chem 256: 4772-4777, 1981
40. Chen V, Ianuzzo CD, Fong BC, Spitzer JJ: The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes 33: 1078-1084, 1984
41. Eckel J, Reinauer H: Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes induced alter-ations. Biochem Soc Trans 18: 1135-1137, 1990
42. Garvey WG, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implication for diabetic cardiomyopathy. Am J Physiol 264: 837-844, 1993
43. Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963
44. Chen V, Ianuzzo CD: Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60: 1251-1256, 1982
45. Kerbey AK, Vary TC, Randle PJ: Molecular mechanisms regulating myocardial glucose oxidation. Basic Res Cardiol 80 (suppl 2): 93-96, 1985
46. Wieland O, Siess E, Schulze-Wethmar FH, van Funcke HG, Winton B: Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: Effects of diabetes, fasting and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 143: 593-601, 1971